22–23 Jul 2026
Heidelberg Congress Center
Europe/Berlin timezone

Does exercise improve survival after a cancer diagnosis? A living systematic review and meta-analysis of randomized controlled trials

23 Jul 2026, 12:15
5m
Heidelberg Congress Center ( Heidelberg Congress Center )

Heidelberg Congress Center

Heidelberg Congress Center

Czernyring 20 69115 Heidelberg Germany
1 - Scientific Poster Thematic Poster Session

Speaker

Rosa Spence (Viertel Cancer Research Centre, Cancer Council Queensland, Brisbane, Queensland, Australia)

Description

Introduction: This project aims to (1) assess the effect of exercise interventions on cancer survival using data from randomized controlled trials (RCTs), and (2) establish an open-access, continuously updated resource synthesizing evidence on exercise and cancer survival.

Methods: A systematic search for this living review (PROSPERO: CRD420251081208) was conducted in October 2025 to identify RCTs evaluating the effect of exercise interventions on survival outcomes in adults diagnosed with cancer. Duplicate study screening is underway. Data extraction, risk of bias, and evidence quality will be independently completed by two authors, with integrity and trustworthiness assessed by one author. Random-effects models will generate pooled hazard ratio (HR) estimates for overall survival and other survival outcomes. When sufficient data exists, subgroup analyses will explore whether participant and intervention characteristics modify effect.

Results: To date, seven eligible trials have been identified after screening 84% of the 26,178 studies retrieved. These trials included 1,942 participants with stage 0-4 hematological, breast, colon, ovarian, or gastrointestinal cancers. Interventions were delivered during treatment (n=2), post-treatment (n=2), or across both periods (n=3), with durations ranging from 12 weeks to 3 years. Most interventions involved aerobic exercise only (n=5); one included a resistance-only arm, and two were mixed-mode. Five trials involved unsupervised exercise. Survival was an exploratory outcome in five trials, with median follow-up ranging from 1.5 to 8.3 years. Preliminary pooled analysis indicates improved overall survival in exercise versus control groups (HR: 0.66, 95% CI: 0.49-0.90; p=0.008). Updated results will be presented following completion of screening and data extraction.

Conclusion: This living review will provide researchers, clinicians, and consumers with real-time, interactive access to evolving evidence on exercise and cancer survival, supporting evidence-based decision-making and accelerating research translation.

Keywords

Survival, exercise intervention, meta-analysis, data visualisation

Abstract submitters declaration yes
Conflict of Interest & Ethical Approval yes

Author

Rosa Spence (Viertel Cancer Research Centre, Cancer Council Queensland, Brisbane, Queensland, Australia)

Co-authors

Brooke Baker (Viertel Cancer Research Centre, Cancer Council Queensland, Brisbane, Queensland, Australia) Melanie Plinsinga (Australian Centre for Precision Health and Technology (PRECISE), Griffith University, Australia) Elizabeth Johnston (Viertel Cancer Research Centre, Cancer Council Queensland, Brisbane, Queensland, Australia) Susannah Ayre (Viertel Cancer Research Centre, Cancer Council Queensland, Brisbane, Queensland, Australia) Jason Martin (Viertel Cancer Research Centre, Cancer Council Queensland, Brisbane, Queensland, Australia) Christine Friedenreich (Departments of Oncology and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada) Kerry S. Courneya (Faculty of Kinesiology, Sport, and Recreation, College of Health Sciences, University of Alberta, Edmonton, Canada) Sandra Hayes (Viertel Cancer Research Centre, Cancer Council Queensland, Brisbane, Queensland, Australia)

Presentation materials

There are no materials yet.